These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35845555)

  • 21. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
    Sridharan K; Abbasi MY; Mulubwa M
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon.
    Setiawan E; Suwannoi L; Montakantikul P; Chindavijak B
    Acta Med Indones; 2019 Jan; 51(1):10-18. PubMed ID: 31073101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.
    Lanke S; Yu T; Rower JE; Balch AH; Korgenski EK; Sherwin CM
    J Clin Pharmacol; 2017 Jan; 57(1):77-84. PubMed ID: 27291466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations.
    Shimamoto Y; Verstegen RHJ; Mizuno T; Schechter T; Allen U; Ito S
    J Antimicrob Chemother; 2021 Oct; 76(11):2932-2940. PubMed ID: 34480578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
    Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
    Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
    Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
    J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia.
    Mizokami F; Shibasaki M; Yoshizue Y; Noro T; Mizuno T; Furuta K
    Clin Interv Aging; 2013; 8():1015-21. PubMed ID: 23966773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation.
    Frymoyer A; Hersh AL; Coralic Z; Benet LZ; Joseph Guglielmo B
    Clin Ther; 2010 Mar; 32(3):534-42. PubMed ID: 20399990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
    Mulubwa M; Griesel HA; Mugabo P; Dippenaar R; van Wyk L
    Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal Insufficiency.
    Le J; Vaida F; Nguyen E; Adler-Shohet FC; Romanowski G; Kim J; Vo T; Capparelli EV
    J Pharmacol Clin Toxicol; 2014; 2(1):1017-1026. PubMed ID: 25309945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R; So H; Seo E; Kim M; Lee J
    PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
    Smit C; Goulooze SC; Brüggemann RJM; Sherwin CM; Knibbe CAJ
    AAPS J; 2021 Apr; 23(3):53. PubMed ID: 33839974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus.
    Mei Q; Ye Y; Zhu YL; Cheng J; Yang HF; Liu YY; Li HR; Li JB
    Int J Antimicrob Agents; 2015 Jun; 45(6):652-6. PubMed ID: 25813394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections.
    Shen K; Fan Y; Yang M; Chen Y; Tao J; Lu G; Zhang H; Huang Q; Zhang J
    Front Pharmacol; 2021; 12():648668. PubMed ID: 33935752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.
    Tseng SH; Lim CP; Chen Q; Tang CC; Kong ST; Ho PC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support.
    Zylbersztajn B; Parker S; Navea D; Izquierdo G; Ortiz P; Torres JP; Fajardo C; Diaz R; Valverde C; Roberts J
    Front Pharmacol; 2021; 12():709332. PubMed ID: 34483917
    [No Abstract]   [Full Text] [Related]  

  • 39. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.